Angiotensin-(1-7) regulates Angiotensin II-induced VCAM-1 expression on vascular endothelial cells

Biochemical and Biophysical Research Communications

Volumn 430, Issue 2, 2013, Pages 642-646

  Zhang, Feng ^a,b   Ren, Jingyi ^a   Chan, Kenneth ^b   Chen, Hong ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Angiotensin II; Angiotensin (1 7); Angiotensin converting enzyme 2; VCAM 1 expression

Indexed keywords

ANGIOTENSIN II; ANGIOTENSIN[1-7]; I KAPPA B KINASE BETA; MESSENGER RNA; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CELL FRACTIONATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE TRANSLOCATION; GENETIC TRANSFECTION; IMMUNOFLUORESCENCE TEST; INHIBITION KINETICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR ENDOTHELIUM;

ANGIOTENSIN I; ANGIOTENSIN II; ATHEROSCLEROSIS; CELL LINE; ENDOTHELIUM, VASCULAR; HUMANS; NF-KAPPA B; PEPTIDE FRAGMENTS; PROTEIN TRANSPORT; RECEPTORS, G-PROTEIN-COUPLED; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84872285484     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.11.098     Document Type: Article

References (28)

1. Galkina E., Ley K. Vascular adhesion molecules in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2007, 27:2292-2301.
2. Cook-Mills J.M., Marchese M.E., Abdala-Valencia H. Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants. Antioxid. Redox. Signal. 2011, 15:1607-1638.
3. Weiss D., Sorescu D., Taylor W.R. Angiotensin II and atherosclerosis. Am. J. Cardiol. 2001, 87:25C-32C.
4. Benigni A., Cassis P., Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol. Med. 2010, 2:247-257.
5. Costanzo A., Moretti F., Burgio V.L., Bravi C., Guido F., Levrero M., Puri P.L. Endothelial activation by angiotensin II through NFkappaB and p38 pathways: involvement of NFkappaB-inducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. J. Cell. Physiol. 2003, 195:402-410.
6. Tummala P.E., Chen X.L., Sundell C.L., Laursen J.B., Hammes C.P., Alexander R.W., Harrison D.G., Medford R.M. Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature: a potential link between the renin-angiotensin system and atherosclerosis. Circulation 1999, 100:1223-1229.
7. Keidar S., Kaplan M., Gamliel-Lazarovich A. ACE2 of the heart: from angiotensin I to angiotensin (1-7). Cardiovasc. Res. 2007, 73:463-469.
8. Tesanovic S., Vinh A., Gaspari T.A., Casley D., Widdop R.E. Vasoprotective and atheroprotective effects of angiotensin (1-7) in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2010, 30:1606-1613.
9. Toton-Zuranska J., Gajda M., Pyka-Fosciak G., Kus K., Pawlowska M., Niepsuj A., Wolkow P., Olszanecki R., Jawien J., Korbut R. AVE 0991-angiotensin-(1-7) receptor agonist, inhibits atherogenesis in apoE-knockout mice. J. Physiol. Pharmacol. 2010, 61:181-183.
10. Ferreira A.J., Murca T.M., Fraga-Silva R.A., Castro C.H., Raizada M.K., Santos R.A. New cardiovascular and pulmonary therapeutic strategies based on the Angiotensin-converting enzyme 2/angiotensin-(1-7)/mas receptor axis. Int. J. Hypertens. 2012, 2012:147825.
11. Rabelo L.A., Alenina N., Bader M. ACE2-angiotensin-(1-7)-Mas axis and oxidative stress in cardiovascular disease. Hypertens. Res. 2011, 34:154-160.
12. Mercure C., Yogi A., Callera G.E., Aranha A.B., Bader M., Ferreira A.J., Santos R.A., Walther T., Touyz R.M., Reudelhuber T.L. Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circ. Res. 2008, 103:1319-1326.
13. Ueda S., Masumori-Maemoto S., Ashino K., Nagahara T., Gotoh E., Umemura S., Ishii M. Angiotensin-(1-7) attenuates vasoconstriction evoked by angiotensin II but not by noradrenaline in man. Hypertension 2000, 35:998-1001.
14. Moon J.Y., Tanimoto M., Gohda T., Hagiwara S., Yamazaki T., Ohara I., Murakoshi M., Aoki T., Ishikawa Y., Lee S.H., Jeong K.H., Lee T.W., Ihm C.G., Lim S.J., Tomino Y. Attenuating effect of angiotensin-(1-7) on angiotensin II-mediated NAD(P)H oxidase activation in type 2 diabetic nephropathy of KK-A(y)/Ta mice. Am. J. Physiol. Renal. Physiol. 2011, 300:F1271-1282.
15. Dhawan P., Su Y., Thu Y.M., Yu Y., Baugher P., Ellis D.L., Sobolik-Delmaire T., Kelley M., Cheung T.C., Ware C.F., Richmond A. The lymphotoxin-beta receptor is an upstream activator of NF-kappaB-mediated transcription in melanoma cells. J. Biol. Chem. 2008, 283:15399-15408.
16. Laxton R.C., Hu Y., Duchene J., Zhang F., Zhang Z., Leung K.Y., Xiao Q., Scotland R.S., Hodgkinson C.P., Smith K., Willeit J., Lopez-Otin C., Simpson I.A., Kiechl S., Ahluwalia A., Xu Q., Ye S. A role of matrix metalloproteinase-8 in atherosclerosis. Circ. Res. 2009, 105:921-929.
17. Zerfaoui M., Suzuki Y., Naura A.S., Hans C.P., Nichols C., Boulares A.H. Nuclear translocation of p65 NF-kappaB is sufficient for VCAM-1, but not ICAM-1, expression in TNF-stimulated smooth muscle cells: differential requirement for PARP-1 expression and interaction. Cell. Signal. 2008, 20:186-194.
18. Collard C.D., Agah A., Reenstra W., Buras J., Stahl G.L. Endothelial nuclear factor-kappaB translocation and vascular cell adhesion molecule-1 induction by complement: inhibition with anti-human C5 therapy or cGMP analogues. Arterioscler. Thromb. Vasc. Biol. 1999, 19:2623-2629.
19. Bovy P.R., Trapani A.J., McMahon E.G., Palomo M. A carboxy-terminus truncated analogue of angiotensin II, [Sar1]angiotensin II-(1-7)-amide, provides an entry to a new class of angiotensin II antagonists. J. Med. Chem. 1989, 32:520-522.
20. Roks A.J., van Geel P.P., Pinto Y.M., Buikema H., Henning R.H., de Zeeuw D., van Gilst W.H. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension 1999, 34:296-301.
21. Zhang F., Hu Y., Xu Q., Ye S. Different effects of angiotensin II and angiotensin-(1-7) on vascular smooth muscle cell proliferation and migration. PLoS ONE 2010, 5:e12323.
22. Pueyo M.E., Gonzalez W., Nicoletti A., Savoie F., Arnal J.F., Michel J.B. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler. Thromb. Vasc. Biol. 2000, 20:645-651.
23. Tham D.M., Martin-McNulty B., Wang Y.X., Wilson D.W., Vergona R., Sullivan M.E., Dole W., Rutledge J.C. Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol. Genomics 2002, 11:21-30.
24. Al-Maghrebi M., Benter I.F., Diz D.I. Endogenous angiotensin-(1-7) reduces cardiac ischemia-induced dysfunction in diabetic hypertensive rats. Pharmacol. Res. 2009, 59:263-268.
25. Giani J.F., Munoz M.C., Pons R.A., Cao G., Toblli J.E., Turyn D., Dominici F.P. Angiotensin-(1-7) reduces proteinuria and diminishes structural damage in renal tissue of stroke-prone spontaneously hypertensive rats. Am. J. Physiol. Renal Physiol. 2010, 300:F272-282.
26. Jiang T., Gao L., Guo J., Lu J., Wang Y., Zhang Y. Suppressing inflammation by inhibiting NF-kappaB pathway contributes to the neuroprotection ofik Angiotensin-(1-7) in rats with permanent cerebral ischemia. Br. J. Pharmacol. 2012.
27. Anton L., Merrill D.C., Neves L.A., Brosnihan K.B. Angiotensin-(1-7) inhibits in vitro endothelial cell tube formation in human umbilical vein endothelial cells through the AT(1-7) receptor. Endocrine 2007, 32:212-218.
28. Stegbauer J., Potthoff S.A., Quack I., Mergia E., Clasen T., Friedrich S., Vonend O., Woznowski M., Konigshausen E., Sellin L., Rump L.C. Chronic treatment with angiotensin-(1-7) improves renal endothelial dysfunction in apolipoprotein E-deficient mice. Br. J. Pharmacol. 2011, 163:974-983.